logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Epigenetic Cancer Therapy Translational Epigenetics 2nd Edition 2nd Steven Gray

  • SKU: BELL-50453988
Epigenetic Cancer Therapy Translational Epigenetics 2nd Edition 2nd Steven Gray
$ 31.00 $ 45.00 (-31%)

4.1

100 reviews

Epigenetic Cancer Therapy Translational Epigenetics 2nd Edition 2nd Steven Gray instant download after payment.

Publisher: Elsevier
File Extension: PDF
File size: 22.7 MB
Pages: 772
Author: Steven Gray
ISBN: 9780323913676, 0323913679
Language: English
Year: 2023
Edition: 2nd

Product desciption

Epigenetic Cancer Therapy Translational Epigenetics 2nd Edition 2nd Steven Gray by Steven Gray 9780323913676, 0323913679 instant download after payment.

Epigenetic Cancer Therapy, Second Edition provides a comprehensive discussion of healthy and aberrant epigenetic biology, along with new discoveries to improve our understanding of cancer epigenetics and therapeutics. The book encompasses large-scale intergovernmental initiatives, as well as recent findings across cancer stem cells, rational drug design, clinical trials, and chemopreventative strategies. As a whole, the work articulates and raises the profile of epigenetics as a therapeutic option in the future management of cancer. Since the publication of the first edition of this book, the field of epigenetics has undergone significant change. New epigenetic therapies have been designed and approved for clinical use. Our knowledge of the plasticity of the epigenome in cancer and disease has expanded dramatically, with increasing evidence linking pollution to epigenetic changes in cancer development. This second edition has been fully updated to address these changes, along with promising therapeutic programs such as CRISPR/Cas9 mediated approaches, CAR-T based therapies, epigenetic priming, histone modifications, and similar, transformative advances across synthetic biology and cellular engineering.

Related Products